FDA Updates and Press Announcements on NDMA in Ranitidine (Zantac)
FDA alerts health care professionals and patients to voluntary recall of ranitidine medicines (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - May 10, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Popular Heartburn Drugs Linked to Heightened COVID-19 Risk
A popular form of heartburn medication may increase a person’s risk of developing COVID-19, according to a new study, lengthening the already long list of risk factors for the virus.
In the study, published Tuesday in pre-print form in the American Journal of Gastroenterology, scientists led by Cedars-Sinai Medical Center’s Dr. Brennan Spiegel conducted an online survey involving more than 86,000 people. Among them, more than 53,000 reported abdominal pain or discomfort, acid reflux, heartburn or regurgitation, and answered questions about the medications they took to relieve those symptoms. Of those, more than...
Source: TIME: Health - July 7, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news
Zantac, Ranitidine Pulled From Market, Here Are FDA ’s Latest Cancer Concerns
New findings about N-Nitrosodimethylamine (NDMA) contamination of this type of heartburn medication led to the U.S. Food and Drug Administration ' s (FDA ' s) more drastic action. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - April 2, 2020 Category: Pharmaceuticals Authors: Bruce Y. Lee, Contributor Source Type: news
FDA Calls for Market Removal of Ranitidine FDA Calls for Market Removal of Ranitidine
The agency found through product testing that NDMA contamination in ranitidine, commonly known by the brand name Zantac, can develop over time when the product is stored above room temperature.News Alerts (Source: Medscape Pulmonary Medicine Headlines)
Source: Medscape Pulmonary Medicine Headlines - April 2, 2020 Category: Respiratory Medicine Tags: Gastroenterology News Alert Source Type: news
FDA calls for Zantac products to be pulled from market immediately
The US Food and Drug Administration is requesting that manufacturers pull all prescription and over-the-counter ranitidine drugs, known by the brand name Zantac, from the market immediately, the agency announced on Wednesday. (Source: CNN.com - Health)
Source: CNN.com - Health - April 2, 2020 Category: Consumer Health News Source Type: news
FDA Requests Zantac Be Pulled From the Market
Six months after independent testing first raised the possibility that popular heartburn drug ranitidine (Zantac) might break down into the powerful carcinogen n-nitrosodimethylamine (NDMA), the FDA has asked for the removal of all ranitidine products from the market. (Source: WebMD Health)
Source: WebMD Health - April 2, 2020 Category: Consumer Health News Source Type: news
FDA calls for heartburn drug Zantac to be pulled from market immediately
The US Food and Drug Administration is requesting that manufacturers pull all prescription and over-the-counter ranitidine drugs, known by the brand name Zantac, from the market immediately, the agency announced on Wednesday. (Source: CNN.com - Health)
Source: CNN.com - Health - April 1, 2020 Category: Consumer Health News Source Type: news
FDA Pulls Heartburn Drug Zantac From Market
WEDNESDAY, April 1, 2020 -- All versions of the heartburn drug Zantac (ranitidine) have been pulled from the U.S. market due to possible contamination with a probable human carcinogen, the U.S. Food and Drug Administration said Wednesday.
This is... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 1, 2020 Category: Pharmaceuticals Source Type: news
FDA orders Zantac, other heartburn drugs removed from market due to NDMA contamination
The U.S. Food and Drug Administration ordered drugmakers to remove all prescription and over-the-counter products containing the agent ranitidine from the market immediately due to possible contamination. (Source: Health News - UPI.com)
Source: Health News - UPI.com - April 1, 2020 Category: Consumer Health News Source Type: news
FDA Calls For Heartburn Drug Zantac To Be Pulled From Market Immediately
(CNN) — The US Food and Drug Administration is requesting that manufacturers pull all prescription and over-the-counter ranitidine drugs, known by the brand name Zantac, from the market immediately, the agency announced on Wednesday.
The FDA noted that an ongoing investigation has determined that levels of a contaminant in the heartburn medications increase over time and when stored at higher-than-normal temperatures, poses a risk to public health.
The contaminant, N-nitrosodimethylamine or NDMA, is a probable human carcinogen and the FDA has been investigating levels of it in ranitidine since the summer of 2019.
...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - April 1, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Syndicated CBSN Boston CNN Zantac Source Type: news
All Ranitidine Products (Zantac): Press Release - FDA Requests Removal
The FDA announced it is requesting manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 1, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news
U.S. FDA moves to remove all versions of heartburn drug Zantac from market
Ranitidine will not be available for use in the U.S. after the FDA pulls all remaining prescription and over-the-counter products containing the ingredient found in the heartburn medication Zantac. (Source: CBC | Health)
Source: CBC | Health - April 1, 2020 Category: Consumer Health News Tags: News/Health Source Type: news
FDA Pulls Heartburn Drug Zantac From Market
WEDNESDAY, April 1, 2020 -- All versions of the heartburn drug Zantac (ranitidine) have been pulled from the U.S. market due to possible contamination with a probable cancer-causing chemical, the U.S. Food and Drug Administration said... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 1, 2020 Category: General Medicine Source Type: news
Class 2 medicines recall: Ranitidine 150mg and 300mg tablets
Medreich Plc is recalling all unexpired stock of ranitidine 150mg and 300mg tablets from pharmacies and wholesalers as a precautionary measure due to possible contamination with an impurity N-nitrosod (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - February 3, 2020 Category: Drugs & Pharmacology Source Type: news
